Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000902664-25-004953·HIGHBRIDGE CAPITAL MANAGEMENT LLC
Schedule 13G ownership disclosure
MATINAS BIOPHARMA HLDGS INC
Common Stock, par value $0.0001 per share · CUSIP: 576810303
Event date: 2025-09-30
- Filing-level shares
- 0.00
- Percent of class
- 0%
- HIGHBRIDGE CAPITAL MANAGEMENT, LLC
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-004953
- Form type
- SCHEDULE 13G/A
- Filer
- HIGHBRIDGE CAPITAL MANAGEMENT LLC
- CIK
- CIK 919185
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership